Publications by authors named "Amal Essaouiba"

Diabetes mellitus (DM) is a complex disease with high prevalence of comorbidity and mortality. DM is predicted to reach more than 700 million people by 2045. In recent years, several advanced in vitro models and analytical tools were developed to investigate the pancreatic tissue response to pathological situations and identify therapeutic solutions.

View Article and Find Full Text PDF

Functional differentiation of pancreatic like tissue from human induced pluripotent stem cells is one of the emerging strategies to achieve an pancreas model. Here, we propose a protocol to cultivate hiPSC-derived β-like-cells coupling spheroids and microfluidic technologies to improve the pancreatic lineage maturation. The protocol led to the development of spheroids producing the C-peptide and containing cells positive to insulin and glucagon.

View Article and Find Full Text PDF

Several studies have reported a correlation between pesticides exposure and metabolic disorders. Dichlorodiphenyltrichloroethane (DDT) and permethrin (PMT), two pesticides highly prevalent in the environment, have been associated to dysregulation of liver lipids and glucose metabolisms and non-alcoholic fatty liver disease (NAFLD). However, the effects of DDT/PMT mixtures and mechanisms mediating their action remain unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The scarcity and variability of primary human β-cells limit diabetes research, but human induced pluripotent stem cells (hiPSCs) may offer a solution for studying diabetes and developing treatments.
  • Two strategies were explored for culturing hiPSC-derived pancreatic β-cells in microfluidic biochips, including a conventional 2D monolayer method and a more successful 3D spheroid culture using honeycomb static setups.
  • The 3D spheroids showed increased expression of β-cell markers, better insulin secretion in response to glucose, and improved overall functionality when maintained in biochips, highlighting their potential for advancing diabetes research and therapy.
View Article and Find Full Text PDF

Organ-on-chip technology is a promising tool for investigating physiological in vitro responses in drug screening development, and in advanced disease models. Within this framework, we investigated the behavior of rat islets of Langerhans in an organ-on-chip model. The islets were trapped by sedimentation in a biochip with a microstructure based on microwells, and perfused for 5 days of culture.

View Article and Find Full Text PDF